Amyotrophic lateral sclerosis is a progressive neuromuscular disease characterized by both
lower motor neuron and upper motor neuron dysfunction. Although clinical presentations …

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, leading to
progressive paralysis, dysarthria, dysphagia, and respiratory disabilities. Therapy is mostly …

The care and management of patients with ALS should always be patient focused, with
attention to holistic and emotional aspects of well-being. It is the patient who ultimately …

Background and purpose The aim of this study was to investigate utilization rates, treatment
pathways and survival prognosis in patients with amyotrophic lateral sclerosis (ALS) …

Amyotrophic lateral sclerosis (ALS) may be associated with the wish to hasten death
(WTHD). We aimed to determine the prevalence and stability of WTHD and end-of-life …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease associated
with progressive dysphagia, dysarthria, extremity weakness, and dyspnea. Although there …

Recent technological advances in respiratory support and monitoring have dramatically
enhanced the utility of long-term noninvasive ventilation (NIV). Improved quality of life and …

Sialorrhea should initially be treated with anticholinergic medications. For patients who
remain medically refractory, treatment with botulinum toxin type B (level B; recommendation …

Objective: Motor neuron disease (MND) is an incurable progressive illness, characterized by
incessant deterioration of neuromuscular function. Timely commencement of advance care …

Aim To explore and gain knowledge of the experiences and needs among patients with
amyotrophic lateral sclerosis (ALS) of their decision‐making processes whether to choose …